GGrantIndex
← Leaderboards

Karine Gaelle Le Roch

University Of California Riverside

$9,899,836
Attributed
$14,721,447
Total exposure
8
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.2M · FY201025
$2.5M$1.9M$1.3M$625K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$14,721,447 · 8

By mechanism

R01$14,026,983 · 6
R21$694,464 · 2

Others in their field

Top investigators on “Plasmodium Falciparum

Research focus

Plasmodium FalciparumParasitesMalariaLife Cycle StagesDesignPlasmodiumAntimalarialsGene ExpressionBiologyMolecularGenetic TranscriptionGene Expression RegulationProgramsErythrocytesGenome-WidePlayGenesGenomicsMultidisciplinaryCessation Of LifeNovel TherapeuticsProteinsBaseVirulence

Grant awards (27)

Deciphering the Role of Non-Coding RNAs in Gene Regulation$791,864
R01 · FY2025 · AI · contact PI
RNA-Binding Proteins and RNA-Dependent Proteins - An Emerging Role for RNAs in Plasmodium Biology$215,751
R21 · FY2025 · AI · contact PI
Hit-to-Lead Development of the Kalihinol Scaffold for Malaria Treatment$699,861
R01 · FY2022 · AI
Chromatin structure and control of gene expression in the human malaria parasite$670,380
R01 · FY2022 · AI · contact PI
RAPs-mediated post-transcriptional control in Apicomplexan parasites$560,570
R01 · FY2022 · AI · contact PI
Hit-to-Lead Development of the Kalihinol Scaffold for Malaria Treatment$706,539
R01 · FY2021 · AI
Chromatin structure and control of gene expression in the human malaria parasite$679,710
R01 · FY2021 · AI · contact PI
RAPs-mediated post-transcriptional control in Apicomplexan parasites$560,570
R01 · FY2021 · AI · contact PI
Hit-to-Lead Development of the Kalihinol Scaffold for Malaria Treatment$712,803
R01 · FY2020 · AI
Chromatin structure and control of gene expression in the human malaria parasite$679,710
R01 · FY2020 · AI · contact PI
RAPs-mediated post-transcriptional control in Apicomplexan parasites$560,570
R01 · FY2020 · AI · contact PI
Evolution of the 3D chromatin structure in apicomplexan parasites$248,117
R21 · FY2020 · AI · contact PI
Hit-to-Lead Development of the Kalihinol Scaffold for Malaria Treatment$720,613
R01 · FY2019 · AI
Chromatin structure and control of gene expression in the human malaria parasite$679,710
R01 · FY2019 · AI · contact PI
RAPs-mediated post-transcriptional control in Apicomplexan parasites$560,570
R01 · FY2019 · AI · contact PI
Evolution of the 3D chromatin structure in apicomplexan parasites$230,596
R21 · FY2019 · AI · contact PI
Hit-to-Lead Development of the Kalihinol Scaffold for Malaria Treatment$755,448
R01 · FY2018 · AI
Chromatin structure and control of gene expression in the human malaria parasite$732,941
R01 · FY2018 · AI · contact PI
RAPs-mediated post-transcriptional control in Apicomplexan parasites$588,320
R01 · FY2018 · AI · contact PI
The spatial organization of the Plasmodium genome throughout its infectious cycle$452,972
R01 · FY2016 · AI
The spatial organization of the Plasmodium genome throughout its infectious cycle$451,989
R01 · FY2015 · AI
The spatial organization of the Plasmodium genome throughout its infectious cycle$454,989
R01 · FY2014 · AI
The spatial organization of the Plasmodium genome throughout its infectious cycle$396,836
R01 · FY2013 · AI
Understanding the Role of Nucleosome Turnover in the Malaria Parasite$362,484
R01 · FY2013 · AI · contact PI
Understanding the Role of Nucleosome Turnover in the Malaria Parasite$394,231
R01 · FY2012 · AI · contact PI
Understanding the Role of Nucleosome Turnover in the Malaria Parasite$401,721
R01 · FY2011 · AI · contact PI
Understanding the Role of Nucleosome Turnover in the Malaria Parasite$451,582
R01 · FY2010 · AI · contact PI